MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

MDT

89.64

-0.03%↓

VEEV

281.99

+1.94%↑

A

113.98

-2.16%↓

WBA

11.48

-0.26%↓

HQY

97.59

-2.48%↓

Search

Repligen Corp

Uždarymo kaina

SektoriusSveikatos priežiūra

116.42 -6.16

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

115.05

Max

123.45

Pagrindiniai rodikliai

By Trading Economics

Pajamos

40M

5.8M

Pardavimai

1.6M

169M

P/E

Sektoriaus vid.

466.89

39.857

Pelno marža

3.446

Darbuotojai

1,778

EBITDA

2.7M

36M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+47.81% upside

Dividendai

By Dow Jones

Kitas uždarbis

2025-07-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.4B

6.8B

Ankstesnė atidarymo kaina

122.58

Ankstesnė uždarymo kaina

116.42

Naujienos nuotaikos

By Acuity

3%

97%

3 / 376 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Strong Bearish Evidence

Repligen Corp Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-07-17 23:34; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens Consent Orders for Proposed Acquisitions from Exxon Mobil, Chevron

2025-07-17 21:14; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1 Billion Bitcoin Purchase on Hold

2025-07-17 21:04; UTC

Pagrindinės rinkos jėgos
Įsigijimai, susijungimai, perėmimai

Norfolk Southern Shares Rise on WSJ Report of Union Pacific Acquisition Interest

2025-07-17 23:43; UTC

Rinkos pokalbiai

Gold Edges Higher on Possible Position Adjustments -- Market Talk

2025-07-17 23:42; UTC

Rinkos pokalbiai

Nikkei May Rise on Signs of U.S. Econ Strength -- Market Talk

2025-07-17 22:47; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Maintaining Restrictions for Former Pioneer CEO Scott Sheffield Would Damage FTC's Credibility

2025-07-17 22:46; UTC

Įsigijimai, susijungimai, perėmimai

Potential Rail Merger Could Prompt Berkshire Hathaway to Bid for CSX -- Barrons.com

2025-07-17 22:46; UTC

Įsigijimai, susijungimai, perėmimai

FTC Also Says Exxon Order Disregarded Guidelines and Precedent

2025-07-17 22:43; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Maintaining Restrictions on John Hess's Employment Would 'Damage the FTC's Credibility'

2025-07-17 22:43; UTC

Įsigijimai, susijungimai, perėmimai

FTC: Chevron Order Disregarded FTC Merger Guidelines and Decades of Precedent

2025-07-17 22:40; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025-07-17 22:40; UTC

Įsigijimai, susijungimai, perėmimai

FTC Reopens and Sets Aside Chevron-Hess and Exxon-Pioneer Final Consent Orders

2025-07-17 22:30; UTC

Rinkos pokalbiai
Uždarbis

Netflix Sticks to Its Playbook as Competitive Landscape Changes -- Market Talk

2025-07-17 22:20; UTC

Rinkos pokalbiai
Uždarbis

Global Equities Roundup: Market Talk

2025-07-17 22:20; UTC

Rinkos pokalbiai
Uždarbis

Netflix Focusing Resources on TV Viewers It Hasn't Yet Captured -- Market Talk

2025-07-17 22:04; UTC

Rinkos pokalbiai
Uždarbis

Netflix Redesign Done to Match Current Capabilities -- Market Talk

2025-07-17 22:03; UTC

Įsigijimai, susijungimai, perėmimai

China Threatens to Block Panama Ports Deal Unless Its Shipping Giant Is Part of It -- 2nd Update

2025-07-17 21:58; UTC

Rinkos pokalbiai
Uždarbis

Netflix Internal Data Doesn't Indicate Weaker Consumer Sentiment -- Market Talk

2025-07-17 21:57; UTC

Uždarbis

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025-07-17 21:47; UTC

Uždarbis

Netflix Raises Revenue, Margin Forecasts After Strong Second Quarter -- Update

2025-07-17 21:45; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-07-17 21:45; UTC

Rinkos pokalbiai

Crypto Bills Welcomed by Venture Capital, Trade Group Says -- Market Talk

2025-07-17 21:38; UTC

Įsigijimai, susijungimai, perėmimai

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- 2nd Update

2025-07-17 21:22; UTC

Įsigijimai, susijungimai, perėmimai

Update: Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025-07-17 21:05; UTC

Uždarbis

Netflix Earnings Soar Past Expectations. How a Weak Dollar Helped Boost Results. -- Barrons.com

2025-07-17 21:04; UTC

Įsigijimai, susijungimai, perėmimai

Railroad Operator Union Pacific Exploring Deal for Norfolk Southern -- Update

2025-07-17 21:02; UTC

Įsigijimai, susijungimai, perėmimai

Union Pacific Considering a Norfolk Southern Buyout: Report. -- Barrons.com

2025-07-17 20:59; UTC

Įsigijimai, susijungimai, perėmimai

Basel Medical Group Puts $1B Bitcoin Purchase on Hold

2025-07-17 20:50; UTC

Rinkos pokalbiai
Uždarbis

Tech, Media & Telecom Roundup: Market Talk

2025-07-17 20:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

Akcijų palyginimas

Kainos pokytis

Repligen Corp Prognozė

Kainos tikslas

By TipRanks

47.81% į viršų

12 mėnesių prognozė

Vidutinis 177 USD  47.81%

Aukščiausias 207 USD

Žemiausias 130 USD

Remiantis 14 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Repligen Corp kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

14 ratings

10

Pirkti

4

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

125.31 / 140.7Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Strong Bearish Evidence

Vidutinės trukmės periodas

Strong Bearish Evidence

Ilgalaikis periodas

Strong Bearish Evidence

Rinkos nuotaikos

By Acuity

3 / 376 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Labai stiprus bulių rinkos įrodymas

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Aukščiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.